ライフサイエンスコーパス: lower respiratory tract infection

1 /2012, rhesus macaques developed a transient lower respiratory tract infection.

2 tient population but may progress rapidly to lower respiratory tract infection.

3 ions were usually accompanied by symptoms of lower respiratory tract infection.

4 espiratory status of children with acute RSV lower respiratory tract infection.

5 nts that resulted in two bacteremias and one lower respiratory tract infection.

6 ed paramyxovirus that causes acute upper and lower respiratory tract infection.

7 etiologic association in persons with severe lower respiratory tract infections.

8 se single-stranded RNA virus responsible for lower respiratory tract infections.

9 ation on the incidence of diarrhea and acute lower respiratory tract infections.

10 nuary) and were specifically associated with lower respiratory tract infections.

11 er of days with infection for all, upper, or lower respiratory tract infections.

12 tly licensed for the treatment of severe RSV lower respiratory tract infections.

13 ogy, diagnosis, treatment, and prevention of lower respiratory tract infections.

14 of morbidity in children, results in severe lower respiratory tract infections.

15 ure-positive and culture-negative sepsis and lower respiratory tract infections.

16 e of particular concern in the management of lower respiratory tract infections.

17 e prevention of medically attended RSV acute lower respiratory tract infections.

18 recommendations for targets in children with lower respiratory tract infections.

19 n 83 hospitalized patients <2 years old with lower respiratory tract infections.

20 f infants and young children to severe viral lower respiratory tract infections.

21 deficient (PAD) patients, 4 (5%) adults with lower respiratory tract infection, 1 (2.6%) sputum sampl

22 nfection (343 [45%] infections), followed by lower respiratory tract infections (171 [22%]), gastroin

23 .25]; two studies, 1 681 020 events) and for lower respiratory tract infections (-18.48% [-32.79 to -

24 ctices, provided data for 6771 patients with lower-respiratory-tract infections (3742 [55.3%]) and up

25 One patient developed a lower respiratory tract infection after EBUS-TBNA, requi

26 of hospitalizations for RSV-associated acute lower respiratory tract infection (ALRI) detected by act

27 infant hospitalizations for all-cause acute lower respiratory tract infection (ALRI).

28 ied the epidemiology of RSV-associated acute lower respiratory tract infection (ALRTI) hospitalizatio

29 monia among patients hospitalized with acute lower respiratory tract infections (ALRTIs).

30 nts judged reasonably related to siltuximab (lower respiratory tract infection, anaphylactic reaction

31 cimens from patients hospitalized with acute lower respiratory tract infection and identified factors

32 ered by elective CS had an increased risk of lower respiratory tract infection and juvenile idiopathi

33 ma, oral corticosteroids, or antibiotics for lower respiratory tract infection and less than 2 puffs

34 rising patients with community-acquired mild lower respiratory tract infection and matched controls o

35 eneralisable, causal association between RSV lower respiratory tract infection and subsequent long-te

36 ory syncytial virus (RSV) is responsible for lower respiratory tract infections and annually results

37 f this test for identification of subsequent lower respiratory tract infections and bloodstream infec

38 Mexico/InDRE4487/2009) resulted in upper and lower respiratory tract infections and clinical disease

39 al virus (RSV) is the leading cause of acute lower respiratory tract infections and hospitalizations

40 spiratory syncytial virus (RSV) causes acute lower respiratory tract infections and is the leading ca

41 dictor for the subsequent occurrence of MRSA lower respiratory tract infections and MRSA bloodstream

42 ix [12%]), febrile neutropenia (five [10%]), lower respiratory tract infection, and pneumonia (each t

43 s upper respiratory tract infections, severe lower respiratory tract infections, and exacerbations of

44 cations for skin and soft tissue infections; lower respiratory tract infections; and vancomycin-resis

45 ne candidates were efficacious in preventing lower respiratory tract infection as well as in reducing

46 sthma, and the secondary end points included lower respiratory tract infections, asthma exacerbations

47 children hospitalized at one institution for lower respiratory tract infections between January 1, 20

48 Lower respiratory tract infections by respiratory syncyt

49 Human respiratory syncytial virus (RSV) lower respiratory tract infection can result in inflamma

50 regulated in the lungs of weanling rats with lower respiratory tract infection caused by the respirat

51 Lower respiratory tract infections caused by bacteria ar

52 plays a critical role in the pathogenesis of lower respiratory tract infections caused by respiratory

53 test the hypothesis that PVL contributes to lower respiratory tract infections caused by S. aureus s

54 Lower respiratory tract infections caused by the paramyx

55 Vitamin A deficiency and acute lower respiratory tract infections coexist as important

56 aged >60 yr) patients in health and during a lower respiratory tract infection, community-acquired pn

57 Patients older than 18 years with acute lower-respiratory-tract infections (cough of </=28 days'

58 toring of otherwise healthy infants with RSV lower respiratory tract infection could help identify pa

59 None of ten adults who experienced lower respiratory tract infections due to B. catarrhalis

60 yncytial virus (RSV) is the primary cause of lower respiratory tract infection during childhood and c

61 association study and subsequent symptoms of lower respiratory tract infections during the first year

62 RSV), a human pathogen that can cause severe lower respiratory tract infections, especially in infant

63 ss than 5 years die from diarrhoea and acute lower respiratory-tract infection every year.

64 The World Health Organization estimates that lower respiratory tract infections (excluding tuberculos

65 Lower respiratory tract infections from respiratory sync

66 declined overall, hospitalizations for acute lower respiratory tract infections have increased steadi

67 obstruction in smokers, a predisposition to lower respiratory tract infection, higher exacerbation f

68 We describe C. pneumoniae lower respiratory tract infection in a 19-year-old male

69 thogen, causing otitis media in children and lower respiratory tract infection in adults with chronic

70 athogen causing otitis media in children and lower respiratory tract infection in adults with chronic

71 Moraxella catarrhalis is a common cause of lower respiratory tract infection in adults with chronic

72 he effects of oral corticosteroids for acute lower respiratory tract infection in adults without asth

73 ial virus (RSV) is a primary cause of severe lower respiratory tract infection in children worldwide.

74 syncytial virus (RSV) is the major cause of lower respiratory tract infection in children worldwide.

75 is the leading cause of hospitalization for lower respiratory tract infection in children.

76 ry syncytial virus (RSV) is a major cause of lower respiratory tract infection in children.

77 Klig reviews recent literature about lower respiratory tract infection in children.

78 Jean Klig reviews recent literature about lower respiratory tract infection in children.

79 Jean Klig reviews recent literature about lower respiratory tract infection in children.

80 Jean Klig reviews recent literature about lower respiratory tract infection in children.

81 Jean Klig reviews recent literature about lower respiratory tract infection in children.

82 ient RSV-specific IgG can reduce severity of lower respiratory tract infection in high-risk infants,

83 rged in 2002 as an important cause of severe lower respiratory tract infection in humans, and in vitr

84 virus (RSV) is the most significant cause of lower respiratory tract infection in infancy worldwide.

85 ial virus (RSV) is the major cause of severe lower respiratory tract infection in infants and young c

86 ical evidence has been accumulating that RSV lower respiratory tract infection in infants may be link

87 ial virus (hRSV) is a leading cause of acute lower respiratory tract infection in infants, elderly an

88 important viral pathogen that causes severe lower respiratory tract infection in infants, the elderl

89 syncytial virus (RSV) is the major cause of lower respiratory tract infection in infants, with about

90 Acute bronchiolitis is the most frequent lower respiratory tract infection in infants, yet there

91 al virus (RSV) is the most frequent cause of lower respiratory tract infection in infants.

92 yndrome coronavirus (MERS-CoV) causes severe lower respiratory tract infection in people.

93 alog, efficiently inhibits established acute lower respiratory tract infection in the animals, even w

94 We conclude that PVL does not contribute to lower respiratory tract infection in this nonhuman prima

95 syncytial virus (RSV) is a leading cause of lower respiratory tract infection in young children worl

96 ry syncytial virus is a major cause of acute lower respiratory tract infection in young children, imm

97 yncytial virus (RSV) is the leading cause of lower respiratory tract infection in young infants world

98 sative agent of otitis media in children and lower respiratory tract infections in adults suffering f

99 gen that causes otitis media in children and lower respiratory tract infections in adults with chroni

100 mon cause of otitis media in children and of lower respiratory tract infections in adults with chroni

101 thogen, causing otitis media in children and lower respiratory tract infections in adults with chroni

102 ortant cause of otitis media in children and lower respiratory tract infections in adults with chroni

103 ortant cause of otitis media in children and lower respiratory tract infections in adults with chroni

104 er, this bacterium is also a common cause of lower respiratory tract infections in adults with underl

105 titis media and sinusitis in children and of lower respiratory tract infections in adults.

106 al virus (RSV) is a major cause of upper and lower respiratory tract infections in children for which

107 irus (RSV) is the leading etiologic agent of lower respiratory tract infections in children, but no l

108 amily Paramyxoviridae, is a leading cause of lower respiratory tract infections in children, the elde

109 virus (hRSV) is the leading cause of severe lower respiratory tract infections in children.

110 tial virus (RSV) is a leading cause of acute lower respiratory tract infections in children.

111 syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children.

112 t have a statistically significant effect on lower respiratory tract infections in elderly nursing ho

113 e susceptibility and exaggerated response to lower respiratory tract infections in general rather tha

114 hPIV3, cause the majority of acute upper and lower respiratory tract infections in humans, particular

115 ia pneumoniae is a common cause of upper and lower respiratory tract infections in immunocompetent pa

116 the major etiologic agent of severe epidemic lower respiratory tract infections in infancy.

117 yncytial virus (RSV) is the leading cause of lower respiratory tract infections in infant and elderly

118 irus (RSV) is the most common cause of viral lower respiratory tract infections in infants and childr

119 ry syncytial virus (RSV) is a major cause of lower respiratory tract infections in infants and the el

120 ed as a worldwide agent of serious upper and lower respiratory tract infections in infants and young

121 e most common viral pathogens causing severe lower respiratory tract infections in infants and young

122 e most frequent cause of hospitalization for lower respiratory tract infections in infants and young

123 hRSV is a leading cause of lower respiratory tract infections in infants and young

124 yncytial virus (RSV) is the leading cause of lower respiratory tract infections in infants, a safe an

125 scovered paramyxovirus that causes upper and lower respiratory tract infections in infants, the elder

126 ed RNA genome viruses, is a leading cause of lower respiratory tract infections in infants, young chi

127 s influenzae (NTHI) is an important cause of lower respiratory tract infections in patients with chro

128 syncytial virus (RSV) can cause devastating lower respiratory tract infections in preterm infants or

129 Lower respiratory tract infections in the first years of

130 sociated with an increased risk of upper and lower respiratory tract infections in the outpatient set

131 nts with non-CF bronchiectasis and 3 or more lower respiratory tract infections in the preceding year

132 In adults, it causes lower respiratory tract infections in the setting of chr

133 yncytial virus (RSV) is the leading cause of lower respiratory tract infections in the very young.

134 human respiratory pathogen causing upper and lower respiratory tract infections in young children and

135 RSV is a major cause of serious lower respiratory tract infections in young children and

136 yncytial virus (RSV) is the leading cause of lower respiratory tract infections in young children glo

137 is an emerging respiratory virus that causes lower respiratory tract infections in young children wor

138 a single-stranded DNA parvovirus that causes lower respiratory tract infections in young children wor

139 SV has been known for decades to cause acute lower respiratory tract infections in young children, wh

140 s the single most important cause of serious lower respiratory tract infections in young children, ye

141 s the single most important cause of serious lower respiratory tract infections in young children, ye

142 s the single most important cause of serious lower respiratory tract infections in young children, ye

143 Human metapneumovirus (HMPV) causes lower respiratory tract infections in young children.

144 avirus 1 (HBoV1), a human parvovirus, causes lower respiratory tract infections in young children.

145 tory epithelium and is an important cause of lower respiratory tract infections in young children.

146 y syncytial virus (RSV) is the main cause of lower respiratory tract infections in young children.

147 ncytial virus (RSV) is an important cause of lower-respiratory-tract infection in children and elderl

148 moxicillin provides little benefit for acute lower-respiratory-tract infection in primary care both o

149 PV) is a major causative agent of upper- and lower-respiratory-tract infections in infants, the elder

150 bacterium commonly associated with upper and lower respiratory tract infections, including otitis med

151 atory tract infections, but the incidence of lower respiratory tract infections increased as CD4 coun

152 After adjusting for age, smoking, and prior lower respiratory tract infections, increased prevalence

153 erved CD4 cell counts are at higher risk for lower respiratory tract infections, indicating impaired

154 he epithelial secretome participating in RSV lower respiratory tract infection-induced airway remodel

155 Head and Neck, Upper Respiratory Infections, Lower Respiratory Tract infections, Infections of the Ga

156 ococcus pneumoniae, the transition to severe lower respiratory tract infection is associated with an

157 Acute lower respiratory tract infection is common and often tr

158 Respiratory syncytial virus (RSV) lower respiratory tract infection is implicated in asthm

159 Acute lower respiratory tract infection is responsible for an

160 Lower-respiratory-tract infection is one of the most com

161 e in infancy, specifically the occurrence of lower respiratory tract infection, is associated with lo

162 Lower respiratory tract infection (LRI) is a leading cau

163 al virus (RSV) is the leading cause of viral lower respiratory tract infection (LRTI) and hospitaliza

164 that can predict the risk of progression to lower respiratory tract infection (LRTI) and RSV-associa

165 that there is no effective treatment for RSV lower respiratory tract infection (LRTI) and that suppor

166 (RSV) upper respiratory tract infection and lower respiratory tract infection (LRTI) but is associat

167 Lower respiratory tract infection (LRTI) commonly causes

168 Distinguishing between bacterial and viral lower respiratory tract infection (LRTI) remains challen

169 cumented pneumonia, and secondary outcome, a lower respiratory tract infection (LRTI) without radiogr

170 r respiratory tract infection (URTI) without lower respiratory tract infection (LRTI), URTI progressi

171 e most common reason for hospitalization was lower respiratory tract infection (LRTI).

172 fluenza virus are common causes of infantile lower respiratory tract infection (LRTI).

173 al significance remains unclear in pediatric lower respiratory tract infection (LRTI).

174 is to 5.84 (95% CI 5.61-6.08; p < 0.001) for lower respiratory tract infection (LRTI).

175 Lower respiratory tract infections (LRTIs) are a persist

176 ry syncytial virus (RSV) and rhinovirus (RV) lower respiratory tract infections (LRTIs) being strongl

177 se single-stranded RNA virus responsible for lower respiratory tract infections (LRTIs) in humans.

178 per respiratory tract infections (URTIs) and lower respiratory tract infections (LRTIs) was collected

179 0.7%) presented with a severe illness: 2 had lower respiratory tract infections (LRTIs) with low-dens

180 ses of asthma exacerbations in children, and lower respiratory tract infections (LRTIs), caused by vi

181 logical pathogen in hospitalized adults with lower respiratory tract infections (LRTIs).

182 and increased dissemination to blood in the lower respiratory tract infection model.

183 multiplier equal to the ratio of the median lower respiratory tract infection mortality rate in each

184 espiratory syncytial virus (RSV) causes more lower respiratory tract infections, often manifested as

185 were diagnosed in patients with symptoms of lower respiratory tract infection or acute allograft dys

186 ion for ICU-acquired MRSA infections, either lower respiratory tract infection or bloodstream infecti

187 Comparison of lower respiratory tract infections over the first 4 days

188 egalovirus (CMV) antigenemia (p = 0.005) and lower respiratory tract infection (p = 0.003) and no leu

189 re, there is evidence of clinical failure in lower respiratory tract infection patients, but in most

190 Lower respiratory tract infections-pneumonia, atypical p

191 are typically young children with upper and lower respiratory tract infection, presenting with sympt

192 to develop respiratory syncytial virus acute lower respiratory tract infection.Respiratory syncytial

193 nfection or bloodstream infection, was poor (lower respiratory tract infection: sensitivity, 24.2%; s

194 corticosteroids should not be used for acute lower respiratory tract infection symptoms in adults wit

195 rved for duration or severity of other acute lower respiratory tract infection symptoms, duration of

196 outcomes were duration and severity of acute lower respiratory tract infection symptoms, duration of

197 st that hMPV is a cause of clinically severe lower respiratory tract infection that can be detected d

198 actors of PIV acquisition and progression to lower respiratory tract infection, their impact on trans

199 ibed paramyxovirus associated with upper and lower respiratory-tract infection (URI and LRI, respecti

200 We assessed the seasonality of viral lower respiratory tract infections (V-LRI), bacteremic p

201 99.6% of in-county children hospitalized for lower respiratory tract infections were admitted to Cinc

202 nfectious events (SIEs) (gastroenteritis and lower respiratory tract infections) were investigated fo

203 Progression to lower respiratory tract infection with clinical and radi

204 with cystic fibrosis (CF) are susceptible to lower respiratory tract infections with Pseudomonas aeru

205 ratory infections (comprising both upper and lower respiratory tract infections with viruses, bacteri

206 Lower-respiratory-tract infection with parainfluenza (od

207 ctable after infection and was strongest for lower-respiratory-tract infection with parainfluenza vir

208 benefits and harms of amoxicillin for acute lower-respiratory-tract infection with those of placebo

209 virus (RSV) is the cause of one-fifth of all lower respiratory tract infections worldwide and is incr

210 virus (RSV) is the cause of one-fifth of all lower respiratory tract infections worldwide and is incr